Comparative efficacy of commercial oral poly-herbal traditional Chinese medicine formulations combined with western medicine in benign prostatic hyperplasia management: a systematic review and network meta-analysis
Zeng H, Wang Z, Zhu W, Li X, Liu B, Chen C, Huang P, Luo Y · Frontiers in Pharmacology · 2024 June 05
DOI 10.3389/fphar.2024.1358340
Objective
To investigate the comparative effectiveness and safety of commonly used oral poly-herbal traditional Chinese medicine formulations combined with Western medicine for treating benign prostatic hyperplasia using a network meta-analysis.
Conclusions
The study concluded that combining oral poly-herbal traditional Chinese medicine formulations with Western medicine may provide greater therapeutic benefits than Western medicine alone for benign prostatic hyperplasia, with Jingui Shenqi pill, Guizhi Fuling capsule, Pulean tablet, and Huange capsule emerging as promising options.
Critical Appraisal
Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.
This article has not yet been critically appraised by the Research Hub.
Learn more about Critical Appraisal
